These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17766736)

  • 1. Sugammadex: an opportunity for more thinking or more cookbook medicine?
    Donati F
    Can J Anaesth; 2007 Sep; 54(9):689-95. PubMed ID: 17766736
    [No Abstract]   [Full Text] [Related]  

  • 2. Sugammadex: the first selective binding reversal agent for neuromuscular block.
    Kovac AL
    J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat dosing of rocuronium after reversal of neuromuscular block by sugammadex.
    Matsuki G; Takahata O; Iwasaki H
    Can J Anaesth; 2011 Aug; 58(8):769-70. PubMed ID: 21614668
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized simultaneous comparison of acceleromyography with a peripheral nerve stimulator for assessing reversal of rocuronium-induced neuromuscular blockade with sugammadex.
    Drobnik L; Sparr HJ; Thörn SE; Khuenl-Brady KS; Rietbergen H; Prins ME; Ullman J
    Eur J Anaesthesiol; 2010 Oct; 27(10):866-73. PubMed ID: 20523215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical pharmacology of sugammadex.
    Bom A; Hope F; Rutherford S; Thomson K
    J Crit Care; 2009 Mar; 24(1):29-35. PubMed ID: 19272536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sugammadex: a new approach to muscle relaxation and its reversal].
    Duvaldestin P
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S39-40. PubMed ID: 19887275
    [No Abstract]   [Full Text] [Related]  

  • 8. Can sugammadex save a patient in a simulated 'cannot intubate, cannot ventilate' situation?
    Bisschops MM; Holleman C; Huitink JM
    Anaesthesia; 2010 Sep; 65(9):936-41. PubMed ID: 21198485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sugammadex, a revolutionary new drug to reverse neuromuscular block].
    Alvarez Gómez JA
    Rev Esp Anestesiol Reanim; 2007 Apr; 54(4):205-7. PubMed ID: 17518169
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of sugammadex to reverse rocuronium in a patient with myotonic dystrophy.
    Petrovski J
    Anaesth Intensive Care; 2011 May; 39(3):505-6. PubMed ID: 21678593
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuromuscular transmission: new concepts and agents.
    de Boer HD
    J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of sugammadex in rapid sequence induction and intubation.
    McCahon R
    Br J Anaesth; 2012 Jul; 109(1):123; author reply 123-4. PubMed ID: 22696561
    [No Abstract]   [Full Text] [Related]  

  • 13. Rocuronium and sugammadex for rapid sequence induction of obstetric general anaesthesia.
    Kessell G; Trapp JN
    Acta Anaesthesiol Scand; 2012 Mar; 56(3):394; author reply 394-5. PubMed ID: 22221068
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
    Pühringer FK; Rex C; Sielenkämper AW; Claudius C; Larsen PB; Prins ME; Eikermann M; Khuenl-Brady KS
    Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugammadex, rocuronium and mast cell numbers in the rat liver.
    Platt PR; Sadleir PH; Clarke RC
    Anaesthesia; 2013 Feb; 68(2):208-9. PubMed ID: 23298349
    [No Abstract]   [Full Text] [Related]  

  • 16. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex.
    Eleveld DJ; Kuizenga K; Proost JH; Wierda JM
    Anesth Analg; 2007 Mar; 104(3):582-4. PubMed ID: 17312212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of rocuronium and sugammadex in a patient with dermatomyositis.
    Suzuki T; Nameki K; Shimizu H; Shimizu Y; Nakamura R; Ogawa S
    Br J Anaesth; 2012 Apr; 108(4):703. PubMed ID: 22419633
    [No Abstract]   [Full Text] [Related]  

  • 18. Sugammadex in clinical practice.
    Mirakhur RK
    Anaesthesia; 2009 Mar; 64 Suppl 1():45-54. PubMed ID: 19222431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
    Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
    Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugammadex to reverse rocuronium and facilitate intraoperative motor evoked potentials monitoring during spinal surgery.
    Batistaki C; Papadopoulos K; Kalimeris KA; Soultanis K; Alevizou A; Pantazi M; Kostopanagiotou GG
    Anaesth Intensive Care; 2012 Nov; 40(6):1073-4. PubMed ID: 23194241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.